Reporting of plasma concentration data etc [Bioanalytics]

posted by nobody – 2014-09-19 18:01 (4300 d 09:31 ago) – Posting: # 13542
Views: 14,784

❝ I just don't like the inconsistency of the labs. Some go with 3 decimal places, some go with 3 significant figures.


Isn't there anything in the guidances? ;-)

Start a controlled correspondence with the FDA?

The "4 digits" approach is reasonable, ask your lab in the analytical study plan to provide the data in the format you like, or are you the poor one who get's the data after all is finished? :-(

PS: Found it...

"A presentation of numeric data that is consistent with instrumental capabilities and acceptance criteria. The method should indicate what format to use to report results (e.g., percentage label claim, weight/weight, and weight/volume etc.) with the specific number of significant figures needed.

The American Society for Testing and Materials (ASTM)E29 describes a standard
practice for using significant digits in test data to determine conformance with specifications."

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM386366.pdf

In the bioanalytical method validation guidance there is nothing on significant digits...

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
357 visitors (0 registered, 357 guests [including 21 identified bots]).
Forum time: 03:32 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5